TESTING FOR CLOPIDOGREL AND ASPIRIN ANTI-PLATELET ACTIVITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES (ACS): SHOULD WE TEST, AND IF SO WHEN?

被引：0
|
作者：
Worrall, A. P. [1 ]
Amoah, V. [1 ]
Nevill, A. [2 ]
Cotton, J. M. [1 ]
机构：
[1] New Cross Hosp, Heart & Lung Ctr, Wolverhampton, W Midlands, England
[2] Biomed Sci Res Inst, Wolverhampton, W Midlands, England
来源：
HEART | 2010年 / 96卷
关键词：
D O I：
10.1136/hrt.2010.196071.25
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A61 / A61
页数：1
相关论文
共 50 条
  • [31] Evaluation of triple anti-platelet therapy by modified thrombelastography in patients with acute coronary syndrome
    REN YihongYANG TingshuWANG YuGAI LuyueLIU HongbinCHEN LianWANG HongyeWANG ChunyaXU XiuliJIN JingXIN YouhongLI RongbinLI HaiyanLIN Lin and LIU Chunxue Department of CardiologyGeneral Hospital of the Chinese Peoples Liberation ArmyBeijing China
    中华医学杂志(英文版), 2008, (09) : 850 - 852
  • [32] Prior Clopidogrel Therapy in Patients Presenting with Acute Coronary Syndromes (ACS) is Associated with Increase Risk of Stent Thrombosis
    Asher, Elad
    Biton, Yitsik
    Fink, Noam
    Herscovici, Romana
    Koifman, Edward
    Maor, Elad
    Sabbag, Avraham
    Fefer, Paul
    Beigel, Roy
    Matezky, Shlomi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B141 - B141
  • [33] Ticagrelor was associated with lower fracture risk than clopidogrel in the dual anti-platelet regimen among patients with acute coronary syndrome treated with percutaneous coronary intervention
    Lui, D. T. W.
    Wong, C. H.
    Ip, A.
    Ng, A. K. Y.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (04) : 895 - 902
  • [34] Ticagrelor was associated with lower fracture risk than clopidogrel in the dual anti-platelet regimen among patients with acute coronary syndrome treated with percutaneous coronary intervention
    D. T. W. Lui
    C. H. Wong
    A. Ip
    A. K. Y. Ng
    Journal of Endocrinological Investigation, 2024, 47 : 895 - 902
  • [35] Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study
    Angiolillo, Dominick J.
    Saucedo, Jorge F.
    DeRaad, Roger
    Frelinger, Andrew L.
    Gurbel, Paul A.
    Costigan, Timothy M.
    Jakubowski, Joseph A.
    Ojeh, Clement K.
    Effron, Mark B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : 1017 - 1023
  • [36] DUAL ANTI-PLATELET THERAPY AFTER CORONARY STENTING IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS): COSTS AND BENEFITS OF SELECTING THERAPY DURATION BY INDIVIDUAL BLEEDING RISK
    Olchanski, Natalia
    van Klaveren, David
    Cohen, Joshua T.
    Kent, David M.
    MEDICAL DECISION MAKING, 2020, 40 (01) : E203 - E204
  • [37] Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests
    Shenkman, Boris
    Matetzky, Shlomi
    Fefer, Paul
    Hod, Hanoch
    Einav, Yulia
    Lubetsky, Aharon
    Varon, David
    Savion, Naphtali
    THROMBOSIS RESEARCH, 2008, 122 (03) : 336 - 345
  • [38] Anti-platelet effect of aspirin in medically treated patients with acute myocardial infarction: Influence of age and gender
    Santos, M. T.
    Valles, J.
    Madrid, I
    Bonastre, J.
    Moscardo, A.
    Ruano, M.
    Latorre, A. M.
    Santos, M. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 760 - 760
  • [39] Survival Outcome of Patients in Acute Variceal Bleeding With Acute Coronary Syndrome Discharged on Anti-Platelet Agents
    Parkash, Om
    Kumar, Rajesh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1553 - S1553
  • [40] Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes - Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
    Peters, RJG
    Mehta, SR
    Fox, KAA
    Zhao, F
    Lewis, BS
    Kopecky, SL
    Diaz, R
    Commerford, PJ
    Valentin, V
    Yusuf, S
    CIRCULATION, 2003, 108 (14) : 1682 - 1687
12345